| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
p53 Lacks Intrinsic Transcriptional Activity and Reveals the Critical Role of Nuclear Import in Dominant-Negative ActivityDepartment of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong
Requests for reprints: Randy Y.C. Poon, Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong. Phone: 852-2358-8703; Fax: 852-2358-1552; E-mail: bcrandy{at}ust.hk.
The transcription factor p53 is one of the most frequently mutated tumor suppressors. Recent progress has unraveled several novel isoforms of p53. Intriguingly, one of the p53 isoform,
p53, which lacks part of the DNA binding domain, was reported to be transcriptionally active toward some p53 target genes and is critical for the intraS phase checkpoint. Here, we show that, in contrast to full-length p53, ectopically expressed
p53 neither transactivated the promoters of p21CIP1/WAF1 or murine double minute-2 (MDM2) nor repressed the cyclin B1 promoter in unstressed H1299 cells. Due to the deletion of a nuclear localization signal,
p53 was not imported into the nucleus. Engineering of nuclear localization signals to
p53 restored nuclear accumulation. However, the nuclear-targeting
p53 remained inactive, indicating that the lack of intrinsic activity of
p53 was not simply due to subcellular localization but to its incomplete DNA binding domain. Similar to p53,
p53 was subjected to MDM2-mediated ubiquitination/proteolysis. The cytoplasmic localization of
p53 correlated with the instability of the protein because forcing
p53 into the nucleus increased its stability. Although
p53 could form a complex with p53 and stimulated the cytoplasmic retention of p53, it was not a robust inhibitor of p53. Targeting
p53 into the nucleus enhanced the dominant-negative activity of
p53. These observations underscore the critical role of subcellular localization in the dominant-negative action of p53. [Cancer Res 2007;67(5):195969]
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |